IP Library › Assignment 049179/0171
Patent Assignment
Reel/Frame 049179/0171

Change of Name

Recorded: 2019-05-14 Pages: 4
Assignor
BIO-THERA SOLUTIONS, LTD., CO.
Executed: 2011-09-19
Assignee
BIO-THERA SOLUTIONS, LTD.
A6-5FL., 11 KAIYUAN RD, SCIENCE CITY, HIGH-TECH INDUSTRIAL DEVELOPMENT ZONE, GUANGZHOU, 510530, CHINA
Covered Properties (6)
Compounds and Methods for the Treatment of Egfr Positive Diseases
Patent: 9,314,536 →
Application: 13/835,537 →
Publication: US 2014/0178412
Preparation of Maytansinoid Esters
Patent: 8,889,855 →
Application: 13/836,469 →
Publication: US 2014/0179917
Maytansinoid Derivatives
Patent: 9,345,786 →
Application: 13/837,783 →
Publication: US 2014/0178414
Maytansinoid Derivatives
Patent: 8,877,706 →
Application: 13/838,868 →
Publication: US 2014/0178415
Compounds and Methods for the Treatment of Erb B2/Neu Positive Diseases
Patent: 9,737,616 →
Application: 14/802,900 →
Publication: US 2015/0320881
Compounds and Methods for the Treatment of Erb B2/Neu Positive Diseases
Application: 15/606,648 →
Publication: US 2017/0258935
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 15, 2013
From: QIN, CHAO; LI, SHENGFENG
To: BIO-THERA SOLUTIONS, LTD., CO.
Reel/Frame 030014/0320 →
Assignment of Assignor's Interest Mar 15, 2013
From: DENG, XIAOBIN
To: BIO-THERA SOLUTIONS, LTD., CO.
Reel/Frame 030015/0709 →
Assignment of Assignor's Interest Mar 15, 2013
From: LI, SHENGFENG; DENG, XIAOBIN; TAN, SONGNUAN; TANG, WEIJIA
To: BIO-THERA SOLUTIONS, LTD., CO.
Reel/Frame 030017/0073 →
Assignment of Assignor's Interest Mar 15, 2013
From: LI, SHENGFENG; DENG, XIAOBIN; TAN, SONGNUAN; TANG, WEIJIA
To: BIO-THERA SOLUTIONS, LTD., CO.
Reel/Frame 030018/0903 →